+1 (202) 780-3397
Sens a heart vs hs-cTnI for rapid diagnosis of ACS
Joint Event on 10th WORLD HEART CONGRESS & 6th International Congress on CARDIOLOGY AND CARDIAC SURGERY
December 02-03, Dubai, UAE
Nikola Bakracheski, Elena Kovacheska Bashuroska
Institute of Cardiovascular Diseases, Macedonia
Scientific Tracks Abstracts : Curr Trend Cardiol
Abstract:
Sens a heart is a unique, novel ultra-sensitive
immunoassay for the rapid diagnosis of myocardial
infarction (myocardial injury) in early phase of ischemic
coronary cascade and in the lates stage of development
of myocardial necrosis. The test is qualitative lateral flow
immunochromatographic assay for the rapid detection
of Cardiac Troponin I ( cTnI) and Heart Fatty Acid Binding
Protein ( H-FABP), which in combination can detect early
signs of AMI (ACS) as soon as 30 minutes after symptom
onset, as compared to the 4 hours wait time of hs-cTnI.
The most significant advantage of Sense-a Heart,
compared to hs-cTnI is its simplicity and easy to use 10
minute test, taken in the early period of ACS, require no
measurement instruments and it can be easly deployed
at the bedside, at the point of patient care, in physician
office, emergency service areas, ambulances without any
laboratory equipment. It requires only a single droplet of
blood (30μL), and it has prominent diagnostic sensitivity
and specificity in patients with ACS.
Biography:
Nikola Bakracheski is the head of Interventional Cardiology Department and Coordinator of Scientific club and CME at the Institute of Cardiovascular Diseases – Ohrid, Macedonia. He has completed his PhD studies in 2016 at University Ss Cyril and Methodius-Skopje. He is a coauthor of several books and scientific papers in the field. He is a member of ESC, EAPCI, Macedonian Society of Cardiology and the Macedonian Medical Association.
E-mail: nbakrac@yahoo.com
PDF HTML